Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00004547 · ClinicalTrials.gov registry record · Phase 2
Treatment of Peritoneal Cancer With Surgery, Perfused Heated Cisplatin and Chemotherapy
A Phase 2 study of Mesothelioma and Abdominal Neoplasm, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- Phase 2
- Development phase
- 188
- Enrollment target
- 1
- Study location
NCT00004547 is a Phase 2 study of Mesothelioma and Abdominal Neoplasm that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 188 participants, roughly in line with the 194-participant average among 46 other Mesothelioma trials with a reported enrollment target. The trial reports 1 study location across 1 state.
The verdict
NCT00004547, a Phase 2 study of Mesothelioma and Abdominal Neoplasm, has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 188 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will test the effectiveness of an experimental treatment for peritoneal cancer involving surgical removal of the tumor, perfusion of the abdomen during surgery with a heated solution of the drug cisplatin, and post-surgery combination chemotherapy in the abdomen with fluorouracil (5-FU) and paclitaxel. Patients with certain peritoneal cancer whose tumors are confined to the abdomen may be eligible for this study. Candidates are screened with a medical history and physical examination, including blood tests, electrocardiogram and possibly bone scan, brain magnetic resonance imaging (MRI), and chest, abdomen and pelvic CT scans. Participants undergo surgery to remove as much tumor as possible. Part of the intestines, pancreas, stomach or the entire spleen may also be removed if they are affected. During surgery, after the tumor has been removed, two catheters (thin plastic tubes) are placed in the abdomen. A chemotherapy solution containing the anti-cancer drug cisplatin heated to a temperature of about 108.6 degrees (10 degrees above normal body temperature) is then delivered into the abdomen through one catheter and drained through another. During treatment, a drug called sodium thiosulfate is given through a vein to reduce the risk of side effects of cisplatin, particularly kidney damage. After 90 minutes of bathing the abdomen with this solution, the drug is rinsed from the abdomen and the catheters removed. Another small catheter is then placed and left inside the abdomen with one end coming out through the skin. Seven to 12 days after the operation, the anti-cancer drugs 5-FU and paclitaxel are given through this catheter. After complete recovery from the surgery, the catheter is removed and the patient is discharged from the hospital. Clinic visits are scheduled for periodic follow-up examination, imaging, and tests 3 and 6 months after surgery and every 6 months for up to 5 years as long as the disease does not worsen. Patients whose disease prog
Conditions Studied
Interventions
- PROCEDURE Surgery
- PROCEDURE Continuous hyperthermic peritoneal perfusion (CHPP) with Cisplatin
- DRUG Postoperative dwell with paclitaxel and 5-FU
Study Locations (1)
Maryland
- National Institutes of Health Clinical Center, 9000 Rockville Pike - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 188 participants |
| Start Date | 2000-01 |
| Est. Completion | 2009-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00004547
The ClinicalTrials.gov registry entry for NCT00004547 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 188 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 194-participant average among 46 other Mesothelioma trials with a reported enrollment target. The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Mesothelioma appearing as the primary indexed condition, and to 3 interventions - of which Surgery is the first listed.
NCT00004547 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT00004547 about?
NCT00004547 is a clinical study titled "Treatment of Peritoneal Cancer With Surgery, Perfused Heated Cisplatin and Chemotherapy". This study will test the effectiveness of an experimental treatment for peritoneal cancer involving surgical removal of the tumor, perfusion of the abdomen during surgery with a heated solution of the drug cisplatin, and post-surgery combination chemotherapy in the abdomen with fluorouracil (5-FU) a...
What is the current status of trial NCT00004547?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 188 participants. The study started on 2000-01. Estimated completion is 2009-08.
What conditions does trial NCT00004547 study?
This clinical trial studies the following conditions: Mesothelioma, Abdominal Neoplasm, Colonic Neoplasm, Peritoneal Neoplasm.
What interventions are being tested in trial NCT00004547?
The interventions under investigation include: Surgery (PROCEDURE), Continuous hyperthermic peritoneal perfusion (CHPP) with Cisplatin (PROCEDURE), Postoperative dwell with paclitaxel and 5-FU (DRUG).
Who is sponsoring clinical trial NCT00004547?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00004547 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Mesothelioma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study of Sacituzumab Govitecan in People With Mesothelioma
RECRUITING · Phase 2
-
Olaparib in Patients With HRD Malignant Mesothelioma
RECRUITING · Phase 2
-
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid Cancers
RECRUITING · Phase 2
-
MAGIC AKI: Magnesium for the Prevention of HIOC-Associated AKI
RECRUITING · Phase 2
-
18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection
RECRUITING · Phase 2
-
A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.